ACNE
Keywords:
Keywords: acne vulgaris, propionobacterium acnes, acne grading, acne treatment, acne psychological effectsAbstract
Abstract: Acne is one of the most prevalent skin conditions affecting teenagers. It is a disease of the pilosebaceous unit. Blockage of sebaceous glands and colonisation with Proionobacterium acnes leads to acne. Grading the severity of acne helps to determine the appropriate treatment. Treatment of acne should be started as early as possible to minimise the risk of scarring and adverse psychological effects. It should be tailored to the individual patient, the type of acne, its severity, the patient's ability to use the treatment, and the psychological state. Topical agents are the mainstay for treatment of mild acne. Moderate acne is treated with oral antibiotics. Resistance to antibiotics may be reduced by subsequent use of non‐antibiotic topical medications. Severe acne is treated with isotretinoin, and this can lead to permanent remission. With better education and care given by medical profession, acne treatment could be significantly improved.
References
James W D. Acne. N Engl J Med 20053521463–1472. [PubMed] [Google Scholar]
Webster G F. Acne vulgaris. BMJ 2002325475–478. [PMC free article] [PubMed] [Google Scholar]
Cunliffe W J, Gould D J. Prevalence of facial acne in late adolescence and in adults. Br J Dermatol 197911109–1110. [PMC free article] [PubMed] [Google Scholar]
Goulden V, Cunliffe W J. Post adolescent acne. A review of the clinical features. Br J Dermatol 199713666–70. [PubMed] [Google Scholar]
Marks R.Acne; advice on clearing your skin. London: Martin Dunitz, 1986
Kraning K K, Odland G R. Prevalence, morbidity and cost of dermatology diseases. J Invest Dermatol 197975(suppl)395–401. [Google Scholar]
Cunliffe W.The acne. London: Dunitz, 1989
Simpson N B.Acne and the mature woman. London: Science Press, 1991
Cunliffe W J, Gorcha P S, Griffiths W A D.et alInterfaces in dermatology. Distance learning programme—acne. London: Medical Action Communication, 1997
Rubinow D R, Peck G L, Squillace K M.et al Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 19871725–32. [PubMed] [Google Scholar]
Layton A M, Knaggs H, Taylor J.et al Isotretinoin for acne vulgaris‐10 years later‐ a safe and successful treatment. Br J Dermatol 1993129292–296. [PubMed] [Google Scholar]
Clark S M, Goulden V, Finlay A Y.et al The psychological and social impact of acne. Student using three disability questionnaires. Br J Dermatol 199713741 [Google Scholar]
Jowett S, Ryan T. Skin disease and handicap; an analysis of the impact of skin conditions. Soc Sci Med 198520425–429. [PubMed] [Google Scholar]
Cunliffe W. Acne and unemployment. Br J Dermatol 1986115386 [PubMed] [Google Scholar]
Gupta M A, Gupta A K, Schnork N J.et al Psychiatric aspects of the treatment of mild to moderate facial acne. Some preliminary observations. Int J Dermatol 199029719–721. [PubMed] [Google Scholar]
Bach M, Bach D. Psychiatric and psychometric issues in acne excoriee. Psychother Psychosom 199360207–210. [PubMed] [Google Scholar]
Koo J Y, Smith L L. Psychogenic aspects of acne. Pediatr Dermatol 199118185–188. [PubMed] [Google Scholar]
Papadopoulos L, Bor R, Legg C. Psychological factors in cutaneous diseases. An overview of research. Psychol Health Med 19994107–126. [Google Scholar]
Baldwin H E. The interaction between acne vulgaris and the psyche. Cutis 200270133–139. [PubMed] [Google Scholar]
Kellet S C, Gawkrodger D J. The psychosocial and emotional impact of acne and the effect of treatment with Isotretinoin. Br J Dermatol 1999140272–282. [PubMed] [Google Scholar]
Cotteril J A, Cunliffe W J. Suicide in dermatology patients. Br J Dermatol 1997137246–250. [PubMed] [Google Scholar]
Mallon E M, Newton J N, Klassen A.et al The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999140672–676. [PubMed] [Google Scholar]
Bataille V, Sneider H, MacGregor A J.et al The influence of genetic and environmental factors in the pathogenesis of acne: a twin study of acne in women. J Invest Dermatol 20021191317–1322. [PubMed] [Google Scholar]
Chiu A, Chon S Y, Kimball A B. The response of skin to stress. Arch Dermatol 2003139897–900. [PubMed] [Google Scholar]
Cunliffe W J, Gollnick H P M.Acne diagnosis and management. London: Martin Dunitz, 2001
Shalita A R. Acne revisited. Arch Dermatol 1994130363–364. [PubMed] [Google Scholar]
Schafer T, Nienhaus A, Vieluf D.et al Epidemiology of acne in general population. The risk of smoking. Br J Dermatol 2001145100–104. [PubMed] [Google Scholar]
Fries J H. Chocolate; A reiew of published reports of allergic and other deleterious effects. Real or presumed. Ann Allergy Asthma Immunol 197841195–207. [PubMed] [Google Scholar]
Fulton J E, Plewing C, Klingman A M. Effect of chocolate on acne vulgaris. JAMA 19692102071–2074. [PubMed] [Google Scholar]
Chu T C. Acne and other facial eruptions. Medicine 19972530–33. [Google Scholar]
Gollnick H, Cunliffe W J, Berson D.et al Management of acne: a report from a global alliance to improve outcomes in Acne. J Am Acad Dermatol 200349(suppl 1)S1–37. [PubMed] [Google Scholar]
Thiboutot D M. An overview of acne and its treatments. Cutis 1996578–12. [PubMed] [Google Scholar]
Feldman S, Careccia R E, Berham K L.et al Diagnosis and treatment of acne. Am Fam Physician 2004692123 [PubMed] [Google Scholar]
Norris J E, Cunliffe W J. A histological and immunocytochemical study of early acne lesions. Br J Dermatol 1988118651–659. [PubMed] [Google Scholar]
Whipp M J, C I. H, Dundas S. Fatal squamous cell carcinoma associated with acne conglobata in a father and daughter. Br J Dermatol 1987117389–392. [PubMed] [Google Scholar]
Veradi D P, Saqueton A C. Perifollicular elastocytosis. Br J Dermatol 197083143–150. [PubMed] [Google Scholar]
O'Brien S C, Lewis J B, Cunliffe W J. The Leeds revised acne grading system. J Dermatolog Treat 19989215–220. [Google Scholar]
Layton A. Psychological assessment of skin disease. Interfaces Dermatol 199419–11. [Google Scholar]
Motley R, Finlay A Y. Acne disability index. Practical use of disability index in the routine management of acne. Exp Dermatol 1992171–3. [PubMed] [Google Scholar]
Kingman A, Mills O. Arch Dermatol. 1972;106:843–850. [PubMed] [Google Scholar]
Cunliffe W J, Holland K T. The effect of benzoyl peroxide in acne. Acta Derm Venereol 198061267–269. [PubMed] [Google Scholar]
Haider A, Shaw J C. Treatment of acne vulgaris. JAMA 2004292726–735. [PubMed] [Google Scholar]
Berson D S, Shalita A R. The treatment of acne; the role of combination therapies. J Am Acad Dermatol 199532532–541. [PubMed] [Google Scholar]
Leyden J J, McGinley K, Mills O K.et al Topical antibiotics and topical antimicrobial agents in acne therapy. Acta Derm Venereol 19808975–81. [PubMed] [Google Scholar]
Brown S K, Shalita A E. Acne vulgaris. Lancet 19983511871–8 [PubMed] [Google Scholar]
Vega B, Jomard A, Michael S. Regulation of toll‐like receptor 2 expression by adapaline. J Eur Acad Dermatol Venereol 200216123–124. [Google Scholar]
Gollnick H, Schram M. Topical drug treatment for acne. Dermatology 1998196119–125. [PubMed] [Google Scholar]
Thiboutot D. New treatment and therapeutic strategies for Acne. Arch Fam Med 20009179–187. [PubMed] [Google Scholar]
Meynadier J, Alirezai M. Systemic anitbiotics for acne. Dermatology 1988196135–139. [PubMed] [Google Scholar]
Golt Z, Ujartanssons S. Oral tetracycline treatment on bacterial flora in acne vulgaris. Arch Dermatol 19669392–100. [PubMed] [Google Scholar]
Layton A. Systemic therapy of acne vulgaris. Br J Hosp Med 20046580–85. [PubMed] [Google Scholar]
Cunliffe W J, Meynadier J, Alirezai M.et al Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle. J Am Acad Dermatol 200349(suppl 3)S218–S226. [PubMed] [Google Scholar]
Eady E A, Cove J H, Holland K T.et al Erythromycin resistant P bacteria in antibiotics treated acne patients; association with therapeutic failure. Br J Dermatol 198912151–57. [PubMed] [Google Scholar]
Cooper A L. Systematic review of P. acne resistance to systemic antibiotics. Med J Aust 1998169259–261. [PubMed] [Google Scholar]
Coates P, Vyakmams S, Eady E A.et al Prevalence of antibiotic resistant P bacteria on the skin of acne patients: a ten year surveilance data and snapshot distribution and study. Br J Dermatol 2002146840–848. [PubMed] [Google Scholar]
Simpson N. Antibiotics in acne; time for rethink. Br J Dermatol 2001144225–228. [PubMed] [Google Scholar]
Ross J, Snelling A M, Eady E A.et al Phenotypic and genotypic characterization of antibiotic resistant P. bacteria isolated from acne patients attending dermatology clinics in Europe, the USA, Japan and Australia. Br J Dermatol 2001144339–345. [PubMed] [Google Scholar]
Tan J K L. Psychosocial impact of acne vulgaris: evaluating the evidence. Skin Therapy Lett. 2004;9: 1–3, 9, [PubMed]
Cunliffe W. Propionibacterium acnes resistance and its clinical relevance. J Dermatolog Treat 19956(suppl 1)S3–S4. [Google Scholar]
Archer J, Archer D. Oral contraceptive efficacy and antibiotic interaction: a myth debunked. J Am Acad Dermatol 200246917–923. [PubMed] [Google Scholar]
Peck G L, Olsen T G, Burkaus D.et al versus placebo in the treatment of cystic acne. A randomised double blind study. J Am Acad Dermatol 19826735–745. [PubMed] [Google Scholar]
King K, Jones D H, Daltry D C.et al A double blind study of the effects of 13‐cis‐retinoic acid on acne sebum excretion rate and microbial population. Br J Dermatol 1982107583–590. [PubMed] [Google Scholar]
Leyden J, James W D. Staphylococcal infection as a complication of isotretinoin therapy. Arch Dermatol 1987123606–608. [PubMed] [Google Scholar]
Simpson N. Effect of isotretinoin on the quality of life of patients with acne. Pharmacoeconomics 19946108–113. [PubMed] [Google Scholar]
Mergel W. How safe is oral isotretinoin? Dermatology 1997195(suppl 1)22–28. [PubMed] [Google Scholar]
Wysoski D K, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with Isotretinoin. J Am Acad Dermatol 200145515–519. [PubMed] [Google Scholar]
Hazen P, Carney J, Walker K.et al Depression‐ a suicide effect of 13‐cis‐retinoic acid therapy. J Am Acad Dermatol 19838278–279. [PubMed] [Google Scholar]
Hull P R, D'Arcy C. Isotretinoin use and subsequent depression and suicide presenting the evidence. Am J Clin Dermatol 20034493–505. [PubMed] [Google Scholar]
Jacobs D G, Deutsch N L, Brewer M. Suicide, depression and isotretinoin. Is there a causal link? J Am Acad Dermatol 200145S168–S175. [PubMed] [Google Scholar]
Ng C H, Schweitzer I. The association between depression and isotretinoin use in acne. Aust N Z J Psychiatry 20033778–84. [PubMed] [Google Scholar]
Pepall L M, Cosgrove M P, Cunliffe W J. Ablation of whiteheads by cautery under topical anaesthesia. Br J Dermatol 1991125256–259. [PubMed] [Google Scholar]
Oringer J S, Kang S, Hamilton T.et al Treatment of acne vulgaris with a pulsed dye laser. JAMA 2004292834–2839. [PubMed] [Google Scholar]
Tsai R Y, Want C N, Chan H L. Aluminium oxide crystal microderm abrasion. A new technique for treating acne scarring. Dermatol Surg 199521539–542. [PubMed] [Google Scholar]
Coleman W P. Dermabrasion and hypertrophic scars. Int J Dermatol 199130629–631. [PubMed] [Google Scholar]
Emst K, Hundeiker M. Results of cryosurgery in 394 patients with hypertrophic scars and keloids. Hautarzt 199546462–466. [PubMed] [Google Scholar]
Green J, Sinclair R D. Perceptions of acne vulgaris in final year medical student. Written examination answers. Australas J Dermatol 20014298 [PubMed] [Google Scholar]
Bradley C. Compliance with drug therapy. Prescriber 19993944–50. [Google Scholar]
Marshall M.From compliance to concordance; achieving shared goals in medicine taking. London: RPS, 1997
